Literature DB >> 15759223

The relationship between mean flow velocity and functional and neurologic parameters of ischemic stroke patients undergoing rehabilitation.

Iuly Treger1, Jonathan Y Streifler, Haim Ring.   

Abstract

OBJECTIVE: To investigate the correlation between mean flow velocity (MFV) as measured by transcranial Doppler ultrasonography (TCD) and functional and neurologic impairment during inpatient rehabilitation after acute stroke.
DESIGN: Prospective study comparing results of rehabilitation in patients with different TCD findings.
SETTING: Acute neurologic rehabilitation department. PARTICIPANTS: Twenty-four consecutive patients admitted to a rehabilitation center with a diagnosis of a first ischemic stroke in the middle cerebral artery (MCA) territory.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Impairment as measured with the National Institutes of Health Stroke Scale (NIHSS) and disability as assessed with the FIM instrument.
RESULTS: Normative or high blood-flow velocity in the MCA of the damaged hemisphere was associated on admission with higher FIM and lower NIHSS scores during 2 months of hospitalization. Absent or low flow velocity correlated with much worse functional and neurologic outcome, especially after 1 and 2 months of inpatient rehabilitation. Statistical correlation was found between MFV in the MCA of the damaged hemisphere, measured by admission TCD, and FIM score on admission and 1 month later. NIHSS scores during hospitalization also correlated with MFV in the MCA of the damaged hemisphere on admission and after 1 month. MFV in the MCA of the undamaged hemisphere 1 month after admission correlated negatively with FIM scores during inpatient rehabilitation.
CONCLUSIONS: Our data showed a correlation between blood-flow velocity in the MCA of both hemispheres and the parameters of functional and neurologic status at different stages of acute inpatient rehabilitation after first ischemic stroke in MCA territory. Cerebral blood flow as measured by TCD can be an additional tool for monitoring the rehabilitation process after stroke.

Entities:  

Mesh:

Year:  2005        PMID: 15759223     DOI: 10.1016/j.apmr.2004.09.004

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  Imaging of perfusion, angiogenesis, and tissue elasticity after stroke.

Authors:  Abraham Martín; Emilie Macé; Raphael Boisgard; Gabriel Montaldo; Benoit Thézé; Mickael Tanter; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-11       Impact factor: 6.200

2.  The Effects of Acupuncture on Cerebral Blood Flow in Post-Stroke Patients: A Randomized Controlled Trial.

Authors:  Motti Ratmansky; Adi Levy; Aviv Messinger; Alla Birg; Lilach Front; Iuly Treger
Journal:  J Altern Complement Med       Date:  2015-11-16       Impact factor: 2.579

3.  Head Position in Stroke Trial (HeadPoST)--sitting-up vs lying-flat positioning of patients with acute stroke: study protocol for a cluster randomised controlled trial.

Authors:  Paula Muñoz-Venturelli; Hisatomi Arima; Pablo Lavados; Alejandro Brunser; Bin Peng; Liying Cui; Lily Song; Laurent Billot; Elizabeth Boaden; Maree L Hackett; Stephane Heritier; Stephen Jan; Sandy Middleton; Verónica V Olavarría; Joyce Y Lim; Richard I Lindley; Emma Heeley; Thompson Robinson; Octavio Pontes-Neto; Lkhamtsoo Natsagdorj; Ruey-Tay Lin; Caroline Watkins; Craig S Anderson
Journal:  Trials       Date:  2015-06-05       Impact factor: 2.279

4.  Effect of head-down tilt on clinical outcome and cerebral perfusion in ischemic stroke patients: A case series.

Authors:  Zi-Ai Zhao; Nan-Nan Zhang; Lin Tao; Yu Cui; Meng Li; Shou-Liang Qi; Hui-Sheng Chen
Journal:  Front Neurol       Date:  2022-09-26       Impact factor: 4.086

5.  Transcranial Color Coded Duplex Sonography Findings in Stroke Patients Undergoing Rehabilitation: An Observational Study.

Authors:  Srikant Venkatakrishnan; Meeka Khanna; Anupam Gupta
Journal:  J Neurosci Rural Pract       Date:  2022-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.